Article

Micro-Surgical Safety Task Force focuses on sutureless vitrectomy

Twenty-five-gauge sutureless vitrectomy has been increasing in popularity. In conjunction with this surge, however, is the observation that the procedure is associated with increased postoperative complications such as hypotony, choroidal detachment, and an increased incidence of endophthalmitis. Richard Kaiser, MD, from the Retina Service of Wills Eye Institute, Philadelphia, focused on endophthalmitis and noted that the 25-gauge procedure has a risk of infection that is 12.4 times greater than the 20-gauge procedure.

Twenty-five-gauge sutureless vitrectomy has been increasing inpopularity. In conjunction with this surge, however, is theobservation that the procedure is associated with increasedpostoperative complications such as hypotony, choroidaldetachment, and an increased incidence of endophthalmitis.Richard Kaiser, MD, from the Retina Service of Wills EyeInstitute, Philadelphia, focused on endophthalmitis and notedthat the 25-gauge procedure has a risk of infection that is 12.4times greater than the 20-gauge procedure.

In light of this, the Micro-Surgical Safety Task Force, composedof experienced retina surgeons, undertook the task ofdisseminating guidelines to reduce the high rate ofendophthalmitis associated with 25-gauge vitrectomy.

Regarding ocular preparation, task force members suggested thatthe lidocaine gel should be rinsed off the ocular surface toallow direct contact of povidone iodine 10% with theconjunctiva.

Intraoperatively, all members of the task force agreed on thefollowing:

  • Conjunctival displacement is important with a cotton tip ratherthan instruments such as forceps or a caliper, thus facilitatingconjunctival displacement without causing microholes.
  • Angled incision may be advantageous over straight-entryincisions because of improved wound closure and for maintainingthe initial postoperative IOP level.
  • Use of antibiotics are important at the end of the case andpostoperatively, but the location varied by surgeon andgentamicin should be avoided because of the potential fortoxicity.
  • An air-fluid exchange at the end of the case may be superiorto filling eyes with fluid, which seem to have a high risk ofdeveloping endophthalmitis, and IOP can be maintained.
  • Using a tapered exit may eliminate vitreous incarceration inthe wound that can occur when the trocar is pulled straight outas the result of a suction effect.
  • Surgeons should maintain a low threshold for placing a sutureat the end of the case.

"There appears to be a higher rate of endophthalmitis followingsutureless vitrectomy," Dr. Kaiser said. "This is an evolvingtechnique. There is a need for continued improvement. TheMicro-Surgical Task Force might be a step in the rightdirection."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.